Podatki
-
Atour Lifestyle Reports $0.33 Q4 EPS, Down 86.1% YoY, as Revenue Surges 33.8% to $2.79B
Atour Lifestyle's Q4 EPS of $0.33 missed the $3.22 estimate by 89.8% despite revenue matching consensus at $2.79B, up 33.8% year-over-year. The post Atour Lifestyle Reports $0.33 Q4 EPS, Down 86.1% YoY, as Revenue Surges 33.8% to $2.79B first appeared on Alphastreet.
AlphaStreet
2026-03-17, 16:02
-
HUYA Stock Plunges: Q4 Revenue Crashes 83.4% YoY to $248.6M, Misses EPS by 106.5%
HUYA posts adjusted loss of $0.01 per share, missing estimates by 106.5%, as Q4 revenue plunges 83% year-over-year to $248.6 million. The post HUYA Stock Plunges: Q4 Revenue Crashes 83.4% YoY to $248.6M, Misses EPS by 106.5% first appeared on Alphastreet.
AlphaStreet
2026-03-17, 15:19
-
XOMA Reports Wednesday Morning as Healthcare Earnings Dominate Sparse Week
Futures flat ahead of sparse earnings calendar; XOMA reports Wednesday morning as healthcare names dominate the week's schedule. The post XOMA Reports Wednesday Morning as Healthcare Earnings Dominate Sparse Week first appeared on Alphastreet.
AlphaStreet
2026-03-17, 15:24
-
Bicycle Therapeutics (BCYC) Q4 Revenue Soars 1194.5% YoY to $48M, Crushing Estimates by 578%
Bicycle Therapeutics narrows Q4 loss to $0.29/share vs $0.95 estimate; revenue of $48M crushes $7.1M consensus by 578%. The post Bicycle Therapeutics (BCYC) Q4 Revenue Soars 1194.5% YoY to $48M, Crushing Estimates by 578% first appeared on Alphastreet.
AlphaStreet
2026-03-17, 14:43
-
Coda Octopus (CODA) Beats Q1 Estimates with $0.08 EPS, Revenue Surges 28.6% YoY to $6.7M
Coda Octopus posts $0.08 EPS vs $0.06 estimate; Q1 revenue of $6.7M climbs 28.6% year-over-year, topping consensus by 7.6%. The post Coda Octopus (CODA) Beats Q1 Estimates with $0.08 EPS, Revenue Surges 28.6% YoY to $6.7M first appeared on Alphastreet.
AlphaStreet
2026-03-17, 14:45
-
CDNL Earnings Preview: What to Watch as Cardinal Infrastructure Reports Q4 Results on March 18
Cardinal Infrastructure reports Q4 2025 on March 19 with no consensus yet available; analysts have sharply raised 2026 estimates in recent weeks. The post CDNL Earnings Preview: What to Watch as Cardinal Infrastructure Reports Q4 Results on March 18 first appeared on Alphastreet.
AlphaStreet
2026-03-17, 14:52
-
Monte Rosa Therapeutics, Inc. (GLUE) Reports Wider Loss Q4 EPS Estimates by 63.4%
Monte Rosa Therapeutics, Inc. (GLUE) reported Q4 2025 GAAP loss of $0.55 per share, a wider loss than the -$0.34 estimate (63.4% wider). The post Monte Rosa Therapeutics, Inc. (GLUE) Reports Wider Loss Q4 EPS Estimates by 63.4% first appeared on Alphastreet.
AlphaStreet
2026-03-17, 14:56
-
Monte Rosa (GLUE) Reports Wider Q4 Loss of $0.55/Share vs $0.34 Estimate, Revenue Misses
Monte Rosa posts Q4 loss of $0.55/share vs $0.34 estimate, revenue of $2.8M misses $5.3M consensus by 47%. The post Monte Rosa (GLUE) Reports Wider Q4 Loss of $0.55/Share vs $0.34 Estimate, Revenue Misses first appeared on Alphastreet.
AlphaStreet
2026-03-17, 15:00
-
Getty Images (GETY) Q4 Revenue Surges 14.1% YoY to $282.3M
Getty Images posts Q4 loss of $0.01 per share vs $0.02 estimate, though revenue of $282.3M beats consensus by 18.5% and grows 14.1% year-over-year. The post Getty Images (GETY) Q4 Revenue Surges 14.1% YoY to $282.3M first appeared on Alphastreet.
AlphaStreet
2026-03-17, 14:21
-
Dragonfly Energy (DFLI) Posts $14.92 Loss Per Share for Q4, Revenue at $13.1M
Dragonfly Energy posts $14.92 per share loss vs $0.30 estimate; Q4 revenue of $13.1M misses consensus $15M despite 6.9% YoY growth. The post Dragonfly Energy (DFLI) Posts $14.92 Loss Per Share for Q4, Revenue at $13.1M first appeared on Alphastreet.
AlphaStreet
2026-03-17, 13:39
-
Semtech (SMTC) Beats Q4 EPS Estimates by 2.0% with $0.44 Earnings, Revenue Climbs 9.3% YoY
Semtech posts Q4 EPS of $0.44, beating the $0.43 estimate by 2.0%, with revenue climbing 9.3% year-over-year to $274.4 million. The post Semtech (SMTC) Beats Q4 EPS Estimates by 2.0% with $0.44 Earnings, Revenue Climbs 9.3% YoY first appeared on Alphastreet.
AlphaStreet
2026-03-17, 13:43
-
FINV Stock: 8 Analysts Issue Buy-or-Better Ratings as FinVolution Delivers $0.25 EPS on Flat Revenue
FinVolution posts $0.25 adjusted EPS on flat $432.4M revenue as eight analysts maintain unanimous Buy-or-better ratings. The post FINV Stock: 8 Analysts Issue Buy-or-Better Ratings as FinVolution Delivers $0.25 EPS on Flat Revenue first appeared on Alphastreet.
AlphaStreet
2026-03-17, 13:47
-
BW Swings to Profit with $0.05 EPS, Beating Estimates by 134.4% on $161M Revenue
BW swings to $0.02 EPS vs. $0.05 loss estimate on $161M revenue, missing top-line consensus by 2.5% as margins drive profitability. The post BW Swings to Profit with $0.05 EPS, Beating Estimates by 134.4% on $161M Revenue first appeared on Alphastreet.
AlphaStreet
2026-03-17, 13:03
-
Microvast (MVST) Q4 Revenue Falls 15% to $96.4M, Adjusted EPS Loss of $0.11 Misses Estimates
Microvast's GAAP EPS of $0.05 beat estimates, but adjusted loss of $0.11 and revenue miss of 26.6% reveal underlying weakness in Q4 2025. The post Microvast (MVST) Q4 Revenue Falls 15% to $96.4M, Adjusted EPS Loss of $0.11 Misses Estimates first appeared on Alphastreet.
AlphaStreet
2026-03-17, 13:06
-
Cango (CANG) Q4 Loss Widens to $0.82/Share vs $0.27 Estimate, Revenue Tops at $1.24B
Cango reports Q4 loss of $0.57/share, 117% wider than expected, despite revenue topping estimates by 72% at $1.24 billion. The post Cango (CANG) Q4 Loss Widens to $0.82/Share vs $0.27 Estimate, Revenue Tops at $1.24B first appeared on Alphastreet.
AlphaStreet
2026-03-17, 13:25
-
Digimarc (DMRC) Swings to Q4 Profit, Beats EPS Estimate by 433.3% with $8.9M Revenue
Digimarc swings to Q4 profit of $0.05 per share vs. consensus loss estimate, with revenue of $8.9M topping the $7.0M forecast. The post Digimarc (DMRC) Swings to Q4 Profit, Beats EPS Estimate by 433.3% with $8.9M Revenue first appeared on Alphastreet.
AlphaStreet
2026-03-17, 12:39
-
Black Diamond Therapeutics (BDTX) Q4 Loss Narrows to $0.27/Share vs $0.17 Estimate
Black Diamond Therapeutics posted a narrower-than-expected Q4 loss of $0.14/share but missed revenue estimates with zero sales. The post Black Diamond Therapeutics (BDTX) Q4 Loss Narrows to $0.27/Share vs $0.17 Estimate first appeared on Alphastreet.
AlphaStreet
2026-03-17, 12:45
-
Ampco-Pittsburgh (AP) Reports $2.85 Per Share Loss on $108.8M Revenue, EBITDA Reaches $3.2M
Ampco-Pittsburgh reports $2.85 per share loss on $108.8M revenue, matching prior quarter's loss as adjusted EBITDA reaches $3.2M. The post Ampco-Pittsburgh (AP) Reports $2.85 Per Share Loss on $108.8M Revenue, EBITDA Reaches $3.2M first appeared on Alphastreet.
AlphaStreet
2026-03-17, 12:55
-
W&T Offshore (WTI) Reports Q4 Loss of $0.14/Share vs $0.12 Estimate, Revenue Increases 1%
W&T Offshore posts $0.37 per share loss, 20.7% wider than estimates, as Q4 revenue reaches $501.5 million against $123.7 million consensus. The post W&T Offshore (WTI) Reports Q4 Loss of $0.14/Share vs $0.12 Estimate, Revenue Increases 1% first appeared on Alphastreet.
AlphaStreet
2026-03-17, 12:11
-
OPAL Fuels Misses Q4 EPS by 94.7% Despite Revenue Rising 24.7% to $99.8M
OPAL Fuels missed Q4 EPS estimates by 94.7% at $0.02 vs $0.38 consensus, though revenue topped forecasts at $99.8M on 25% year-over-year growth. The post OPAL Fuels Misses Q4 EPS by 94.7% Despite Revenue Rising 24.7% to $99.8M first appeared on Alphastreet.
AlphaStreet
2026-03-17, 12:20
-
Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25
Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $1.39 per share, a wider loss than the -$1.19 estimate (16.8% wider). The post Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 first appeared on Alphastreet.
AlphaStreet
2026-03-16, 21:20
-
Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates
Dollar Tree, Inc. (DLTR) turned in Q4 2025 adjusted EPS of $2.56, exceeding the $2.20 Street estimate (beat by 16.4%). The post Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates first appeared on Alphastreet.
AlphaStreet
2026-03-16, 21:06
-
CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25
Q4 2025 loss at CytomX Therapeutics, Inc. (CTMX) widened to $0.20 per share GAAP, worse than the -$0.09 estimate (116.4% wider). The post CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 first appeared on Alphastreet.
AlphaStreet
2026-03-16, 20:26
-
VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25
Q4 2025 loss at VinFast Auto Ltd. (VFS) widened to $0.60 per share GAAP, worse than the -$0.36 estimate (66.7% wider). The post VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 first appeared on Alphastreet.
AlphaStreet
2026-03-16, 19:55
-
VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6%
VNET Group, Inc. (VNET) delivered Q4 2025 adjusted earnings of $0.04 per share, below analysts' $0.18 forecast (miss by 78.2%). The post VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% first appeared on Alphastreet.
AlphaStreet
2026-03-16, 20:12